Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE)
A number of monoclonal antibodies (mAb) are now under investigation in clinical trials to assess their potential role in Systemic Lupus Erythematosus (SLE). The most frequently used mAb is rituximab, which is directed against CD20, a membrane protein expressed on B lymphocytes. Uncontrolled trials r...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI AG
2010-01-01
|
| Серии: | Pharmaceuticals |
| Предметы: | |
| Online-ссылка: | http://www.mdpi.com/1424-8247/3/1/300/ |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|